Bundling next-generation cancer therapies for synergy.
Explore the source record for details and available documents.
Antineoplastic Agents↗
Biomedical subjects
Jim Kling
Publications and source records attributed to Jim Kling.
Moving diagnostics from the bench to the bedside.
Explore the source record for details and available documents.
Diagnostic Equipment↗
Careers in systems biology. Working the systems.
Explore the source record for details and available documents.
Career Choice↗
China offers alternative gateway for experimental drugs.
Explore the source record for details and available documents.
Biotechnology↗
Amgen becomes a stronger cancer player.
Explore the source record for details and available documents.
Antineoplastic Agents↗
Merck moves into biotech.
Explore the source record for details and available documents.
Biological Products↗
Pessimistic response to FDA leadership change.
Explore the source record for details and available documents.
Administrative Personnel↗
The search for a sequencing thoroughbred.
Explore the source record for details and available documents.
Animals↗
Cautious industry welcome for US flu vaccine plan.
Explore the source record for details and available documents.
Bioterrorism↗
Where the future went. In response to market trends and patenting laws, genomics companies are adapting their strategies.
Explore the source record for details and available documents.
Commerce↗
US FDA contemplates collection of pharmacogenomic data.
Explore the source record for details and available documents.
Advisory Committees↗
Roche's microarray tests US FDA's diagnostic policy.
Explore the source record for details and available documents.
Device Approval↗
Ultrafast DNA sequencing.
Explore the source record for details and available documents.
Microfluidics↗